Affordable Access

Access to the full text

Appropriate duration of post-surgical intravenous antibiotic therapy for pyogenic spondylodiscitis

Authors
  • Li, Yun-Da1
  • Wong, Chak-Bor2
  • Tsai, Tsung-Ting1
  • Lai, Po-Liang1
  • Niu, Chi-Chien1
  • Chen, Lih-Huei1
  • Fu, Tsai-Sheng2
  • 1 Chang Gung Memorial Hospital in Linkou, Chang Gung University, Department of Orthopaedic Surgery, Taoyuan, Taiwan , Taoyuan (Taiwan)
  • 2 Chang Gung University, Department of Orthopaedic Surgery, Chang Gung Memorial Hospital in Keelung, 7F, No.222, Maijin Road, Keelung, 20401, Taiwan , Keelung (Taiwan)
Type
Published Article
Journal
BMC Infectious Diseases
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Sep 17, 2018
Volume
18
Issue
1
Identifiers
DOI: 10.1186/s12879-018-3377-1
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundMost guidelines recommend 6 to 12 weeks of parenteral antibiotic treatment for pyogenic spondylodiscitis. When surgical debridement is adequately performed, further intravenous antibiotic treatment duration can be reduced than that of conservative treatment alone theoretically. However, the appropriate duration of post-surgical parenteral antibiotic treatment is still unknown. This study aimed to identify the risk factors of recurrence and evaluate the appropriate duration after surgical intervention.MethodsThis 3-year retrospective review included 102 consecutive patients who were diagnosed with pyogenic spondylodiscitis and underwent surgical intervention. Recurrence was defined as recurrent signs and symptoms and the need for another unplanned parenteral antibiotic treatment or operation within one year. This study included two major portions. First, independent risk factors for recurrence were identified by multivariable analysis, using the database of demographic information, pre-operative clinical signs and symptoms, underlying illness, radiographic findings, laboratory tests, intraoperative culture results, and treatment. Patients with any one of the risk factors were considered high-risk; those with no risk factors were considered low-risk. Recurrence rates after short-term (≤3 weeks) and long-term (> 3 weeks) parenteral antibiotic treatment were compared between the groups.ResultsPositive blood culture and paraspinal abscesses were identified as independent risk factors of recurrence. Accordingly, 59 (57.8%) patients were classified as low-risk and 43 (42.2%) as high-risk. Among the high-risk patients, a significantly higher recurrence rate occurred with short-term than with long-term antibiotic therapy (56.2% vs. 22.2%, p = 0.027). For the low-risk patients, there was no significant difference between short-term and long-term antibiotic therapy (16.0% vs. 20.6%, p = 0.461).ConclusionsThe appropriate duration of parenteral antibiotic treatment in patients with pyogenic spondylodiscitis after surgical intervention could be guided by the risk factors. The duration of postoperative intravenous antibiotic therapy could be reduced to 3 weeks for patients without positive blood culture or abscess formation.

Report this publication

Statistics

Seen <100 times